+91 8208210706   Ozarcare0706@gmail.com

In Stock

Etilaam 1 mg

Etilaam 1Β mg is a prescription medicine used to treat anxiety disorders, panic attacks, and insomnia. It belongs to the class of benzodiazepines, which act on the brain and nerves to produce a calming effect and help reduce anxiety, stress, and tension.

Original price was: ₹1.50.Current price is: ₹1.00.

Category:

Description

Key Benefits

  • Provides quick relief from anxiety and stress

  • Helps in managing panic attacks and nervous tension

  • Promotes better sleep quality and relaxation

  • Reduces restlessness, irritability, and fear

  • Aids in calming the mind and improving focus

  • Supports overall mental balance and well-being


Key Ingredients

  • Etizolam (1 mg): Active ingredient belonging to the benzodiazepine group that enhances the calming effect of GABA neurotransmitters in the brain

  • Excipients: Pharmaceutical-grade inactive ingredients for tablet stability and absorption


Recommended Usage

  • Dosage: As directed by a qualified healthcare professional

  • Usually taken once or twice daily, with or without food

  • Take at the same time each day for best results

  • Do not stop medication suddenly without doctor’s advice


Safety Information

  • Use only under medical supervision

  • May cause drowsiness or dizziness; avoid driving or operating machinery after taking

  • Avoid alcohol consumption while using this medicine

  • Inform doctor if you have liver disease, glaucoma, or history of drug dependence

  • Not recommended during pregnancy or breastfeeding

  • Store in a cool, dry place, away from light and moisture

  • Keep out of reach of children


Disclaimer

This is a prescription-only anti-anxiety medication and should be used strictly under medical guidance.
Self-medication may cause dependency or side effects.
Results may vary depending on individual health condition and response to treatment.

Reviews

There are no reviews yet.

Be the first to review “Etilaam 1 mg”

Your email address will not be published. Required fields are marked *